跳至主要内容
临床试验/NCT03631810
NCT03631810已完成不适用

Contemporary Clinical Management Of Acute Pulmonary Embolism. The COPE Study

Heart Care Foundation181 个研究点 分布在 1 个国家目标入组 5,213 人开始时间: 2018年3月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
5,213
试验地点
181
主要终点
In-hospital death

研究概览

简要总结

Acute pulmonary embolism is a potentially life-threatening disease with short-term mortality ranges from less than 1% to more than 30% during the hospital stay. Recent guidelines recommend to tailor diagnosis hospitalization and acute treatment based on the estimated risk for short-term Death.

The assessment of the contemporary clinical management of patients with acute pulmonary embolism across different specialties would be of crucial value.

详细描述

This is a prospective, non-interventional, multicenter study in patients with acute pulmonary embolism admitted to Cardiology, Emergency and Internal Medicine Departments in Italy.

The aim of the study is to assess contemporary management strategies in patients with acute pulmonary embolism in terms of diagnosis, risk stratification, hospitalization and treatment in Italy and assess

  1. their association with in-hospital and 30-day mortality and
  2. their adherence to current guidelines of the European Society of Cardiology (ESC).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with acute, symptomatic acute pulmonary embolism
  • Age ≥ 18 years
  • Informed consent

排除标准

  • refusal of informed consent
  • participation in controlled trials on the management of patients with acute pulmonary embolism

结局指标

主要结局

In-hospital death

时间窗: 30 days

In-hospital Death and Death at 30 days

次要结局

  • All cause Mortality and clinical worsening(30 days)
  • Pulmonary embolism related mortality for and clinical worsening(30 days)
  • Adherence to guidelines(30 days)

研究者

发起方
Heart Care Foundation
申办方类型
Other
责任方
Sponsor

研究点 (181)

Loading locations...

相似试验

Contemporary Clinical Management Of Acute Pulmonary... | 临床试验